Vonjo 100 MG capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F65U9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,773
Award facts
- Contract value 100% obligated
- $16,773.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,773.40 delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of VONJO 100 MG capsules (120-count units). This non-competitive delivery order carries a firm fixed price structure with an ultimate completion date of February 6, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
VONJO (ruxolitinib) is an oral medication used in the treatment of myelofibrosis and polycythemia vera, specialized hematologic conditions requiring prescription-level pharmaceutical support. This delivery order reflects the contractor's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for military treatment facilities and veterans' healthcare programs. The non-set-aside designation confirms the award was made through open competition, demonstrating AmerisourceBergen's continued capability to meet federal procurement requirements for specialized medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F65U9?
SPE2DR26F65U9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F65U9 worth?
The government has obligated $16,773 on SPE2DR26F65U9.
Is contract SPE2DR26F65U9 an order under another contract?
Yes. SPE2DR26F65U9 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65U9 competed?
The extent of competition for SPE2DR26F65U9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award